MAPT and Alzheimer disease: Available AD drugs, including donepezil, galantamine, rivastigmine and memantine, designed to target these pathological structures, including the amyloid plaque and tau tangle in the brain tissue, can only alleviate the symptoms of AD patients at an early stage [42, 43].